The emerging field of psychedelic psychotherapy

GS Barber, ST Aaronson - Current psychiatry reports, 2022 - Springer
Abstract Purpose of Review Few treatments are available for patients with mood disorders or
post-traumatic stress disorder (PTSD) who have already failed multiple interventions. After …

Hofmann vs. Paracelsus: do psychedelics defy the basics of toxicology?—a systematic review of the main ergolamines, simple tryptamines, and phenylethylamines

LA Henríquez-Hernández, J Rojas-Hernández… - Toxics, 2023 - mdpi.com
Psychedelics are experiencing a strong renaissance and will soon be incorporated into
clinical practice. However, there is uncertainty about how much harm they can cause at what …

Ethical and practical considerations for the use of psychedelics in psychiatry

GS Barber, CC Dike - Psychiatric Services, 2023 - Am Psychiatric Assoc
In recent years, psychedelic-assisted psychotherapies have reentered the realm of rigorous
scientific inquiry, garnering much attention from both the psychiatric community and the …

[HTML][HTML] Interpol Review of Drug Analysis 2019-2022

D Love, NS Jones - Forensic Science International: Synergy, 2023 - ncbi.nlm.nih.gov
Improved methods of analysis, ie, faster, more discriminatory, more sensitive, less costly,
etc., are needed for all abused substances. Additionally, standard analytical data are …

Harm reduction behaviours and harm experiences of people who use 3, 4-methylenedioxymethamphetamine (MDMA) in Aotearoa New Zealand

J Whelan, G Noller, RD Ward - Harm Reduction Journal, 2024 - Springer
Abstract Background 3, 4-Methylenedioxymethamphetamine (MDMA) is drug of high
prevalence in Aotearoa New Zealand and is the primary drug analysed by legal drug …

Comparison of poisoning deaths with wastewater‐based consumption estimates and assessment of fatal toxicity for amphetamine‐type stimulant drugs

P Kriikku, A Kankaanpää, T Gunnar… - Drug testing and …, 2024 - Wiley Online Library
Among several established indicators that are used to monitor the illicit drug scene, drug‐
related deaths and wastewater‐based epidemiology (WBE) stand out for population‐level …

Size matters: comparing the MDMA content and weight of ecstasy tablets submitted to European drug checking services in 2012–2021

RQ Vrolijk, F Measham, A Quesada, A Luf… - Drugs, Habits and …, 2022 - emerald.com
Purpose The 3, 4-methylenedioxymetamphetamine (MDMA) content in ecstasy tablets has
increased enormously throughout Europe across the past decade. This study aims to …

A thematic analysis of MDMA-related harm and harm reduction experiences and knowledge in Aotearoa New Zealand

J Whelan, RD Ward, G Noller - Harm Reduction Journal, 2024 - Springer
Background Methylenedioxymethamphetamine (MDMA) is a popular drug worldwide and
use is prevalent in Aotearoa New Zealand. Although associated with some significant …

What Do Young Adults Expect from the Recreational Use of Ecstasy (3, 4-Methylenedioxymethamphetamine/Molly)? A Latent Class Analysis of a Convenience …

MC De Jonge, AJ Bukman, T Ter Bogt… - European Addiction …, 2023 - karger.com
Introduction: This study offers insights into Dutch young people's expected social and
personal consequences of ecstasy use. Substance use expectancies are assumed to be an …

Developing strategic foresight for drug policy: trends, scenarios, and implications

A Unlu, I Viskari, S Rönkä, T Tammi - Drugs: Education, Prevention …, 2024 - Taylor & Francis
Background This study utilized foresight analysis to project drug policy trends and
challenges in Finland up to 2030. It aimed to develop scenarios and strategies for …